Omega Healthcare has appointed Senthil Velayutham as Chief Technology Officer. He will run the company's global technology and product organisation, including development of the Omega Digital Platform, with a brief to push AI further into healthcare revenue operations. The appointment was announced on 15 September, according to Briefglance and the Fundz executive tracker, and was covered again by The Key Executives on 20 October.
Who he is
Velayutham was previously Chief Product and Technology Officer at Nextiva, which announced his appointment to that role on 29 August 2023. That release lists earlier roles as Chief Product and Technology Officer at Trader Interactive, a Goldman Sachs and Eurazeo portfolio company, and a series of leadership posts at Microsoft, including CTO and Chief Architect for Microsoft Teams, where he helped scale the product. He also worked on Skype for Business and Microsoft Search and AI.
Why Omega wants him
According to Briefglance, Omega CEO Anurag Mehta pointed to Velayutham's experience of putting AI to work in settings where "accuracy, auditability, and trust are non-negotiable." Briefglance reports that Velayutham himself framed the role around the industry settling on what an agentic revenue cycle should look like.
Briefglance also reports that Omega is headquartered in Boca Raton, Florida, describes itself as an AI-driven healthcare solutions company, and works with Microsoft Azure AI and UiPath. It cites client improvements in collections of 20 to 25%. Omega's headcount and revenue were not given in the coverage we reviewed.
A note on timing
This is not a brand-new appointment. It was first announced in mid-September and resurfaced in executive-moves coverage on 20 October, which is when it reached our radar.
The bigger picture
For a company whose business is running revenue operations for healthcare providers, putting a product and platform leader in the CTO seat is a statement of intent. Velayutham's background is in scaling software used by very large numbers of people, rather than in healthcare itself. Our reading is that Omega wants its AI to work as a product across its client base, and that auditability will be the test buyers apply. That is a theme running through this whole issue, from the federal prior authorisation push to the scrutiny of Medicare's WISeR pilot.
What it means for hiring
- When a services-heavy RCM firm hires a product-led CTO from outside healthcare, the next layer down often follows. We would expect interest in product managers, AI engineers and platform architects who can work alongside healthcare domain experts.
- Mehta's emphasis on accuracy, auditability and trust points to demand for people who can show buyers how AI decisions are checked, such as quality, compliance and clinical informatics leads.
- For candidates, RCM is increasingly open to technology leaders from adjacent software sectors, provided they can learn the payer and provider workflows quickly.
Building a team in Digital Health & Healthcare AI?
Issy Eaden specialises in Digital Health & Healthcare AI hiring at QP Group. Talk to Issy about the market, salaries or a search.
Sources
- Omega Healthcare taps veteran CTO to bridge AI's last mile in healthcare · Briefglance · 15 Sep 2026
- Omega Healthcare Recruits Senthil Velayutham to Oversee AI and Digital Platform Development · The Key Executives · 20 Oct 2026
- Omega Healthcare hired (executive tracker) · Fundz · 15 Sep 2026
- Nextiva Welcomes Senthil Velayutham as Chief Product and Technology Officer · Nextiva · 29 Aug 2023
Written by QP Group from the reporting and announcements above. Figures and quotes belong to the original sources.
issy.eaden@qpexec.com
More from Digital Health
- Sustainable Medical Billing adds nearshore teams and rural hospital RCM in one week26 Oct 2026
- Suki raises $90M Series E to stretch its AI assistant past clinical notes26 Oct 2026
- CMS official concedes parts of Medicare's AI prior auth pilot WISeR are failing26 Oct 2026
- Amazon, Google, Meta, Oracle and Axon push prior auth reform into self-funded plans26 Oct 2026
